1. Home
  2. ORRF vs ANNX Comparison

ORRF vs ANNX Comparison

Compare ORRF & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

HOLD

Current Price

$42.60

Market Cap

791.0M

Sector

Finance

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$3.91

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORRF
ANNX
Founded
1919
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
791.0M
873.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ORRF
ANNX
Price
$42.60
$3.91
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$42.00
$16.50
AVG Volume (30 Days)
68.9K
2.6M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
3.29%
N/A
EPS Growth
182.43
N/A
EPS
2.21
N/A
Revenue
$37,144,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.15
$16,320.74
P/E Ratio
$19.16
N/A
Revenue Growth
36.00
N/A
52 Week Low
$31.88
$2.49
52 Week High
$43.81
$7.18

Technical Indicators

Market Signals
Indicator
ORRF
ANNX
Relative Strength Index (RSI) 52.22 25.72
Support Level $40.97 N/A
Resistance Level $42.48 $5.63
Average True Range (ATR) 0.79 0.23
MACD 0.00 -0.11
Stochastic Oscillator 62.55 4.86

Price Performance

Historical Comparison
ORRF
ANNX

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: